HepG2 In Vitro Cell Membrane Integrity-based Apoptosis Assay (FCM)

CAT#: ITS-1022-YF1191
Target Cell Organism: Human
Target Cell Alternative Name: Hep G2
Target Cell Name: HepG2
Assay Type: Detection of Apoptosis Assays
Assay Overview
This assay is to provide HepG2-based In Vitro Cell Membrane Integrity-based Apoptosis Assay (FCM) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HepG2
Target Cell Organism
Human
Target Cell Background
Hep G2 is an immortal cell line which was derived in 1975 from the liver tissue of a 15-year-old Caucasian male from Argentina with a well-differentiated hepatocellular carcinoma. These cells are epithelial in morphology, have a modal chromosome number of 55, and are not tumorigenic in nude mice.
Target Cell Alternative Name
Hep G2
Related Diseases
Hepatocellular Carcinoma
Research Area
Oncology
Assay Name
In Vitro Cell Membrane Integrity-based Apoptosis Assay (FCM)
Short Description
HepG2-cell based In Vitro Cell Membrane Integrity-based Apoptosis Assay (FCM)
Assay Description
FCM is one of the best and accurate automated tecqniques used for the quantification of apoptosis. FCM has been widely used in cancer drug discovery approaches to detect apoptosis. FCM can be used to monitor integrity of cancer cell membranes. Dyes such as PI, fluorescein diacetate, carboxyfluorescein diacetate and TO-PRO-3 are commonly used examples for this purpose in FCM.
Assay Type
Detection of Apoptosis Assays
Assay Type Details
Apoptosis (programmed cell death) plays a vital role in embryonic development, homeostasis, functioning of immune system and wound repair. The ability to evade induction of apoptosis has been used by cancer cells to survive against host defense mechanisms. The molecular mechanisms involved in cancer cell apoptosis have been well documented and it involves certain biochemical events such as DNA fragmentation, chromatin condensation, cell organelle degradation and protein cleavage, etc. The extrinsic and intrinsic (mitochondrial) pathways are the two major pathways involved in apoptosis. With the available techniques and assays, a number of apoptosis inducing agents (natural compounds, synthetic compounds, nano-formulations, peptides and enzymes) in many cancer cells have been identified. Selection of an assay for apoptosis detection is based on factors such as apoptotic pathway, nature of drug, cell type being used and the method of analysis.
Assay Subtype
Flow Cytometry to Detect Apoptosis Assays
Assay MOA
Flow Cytometry Assay
For Research Use Only | Not For Clinical Use
Online Inquiry